Mar 27, 2020
BennuBio, Inc., a provider of advanced cell and particle instrumentation for the life science market, today announced it has closed on $5 million of a $7 million financing round.
Albuquerque, Mar 26, 2020 (Issuewire.com) - The Series B financing was led by new investor Co-Win Ventures with additional investment by existing investors Tramway Venture Partners, Cottonwood Technology Fund, and Sun Mountain Capital. In connection with the financing, Xin Huang of Co-Win Ventures will join BennuBio's Board of Directors.
"We are delighted to have Co-win Ventures lead the financing and are grateful for the continued support of our existing investors. Co-Win has a great track record of investing in successful life science companies," said Steven W. Graves, CEO of BennuBio. "These funds will enable the company to expand our commercial efforts, accelerate the development of new features for our initial product, and further develop additional complementary products."
BennuBio's platform for cell and particle analysis, the VeloCytTM Flow Cytometer, measures critical properties of cells, model tissue systems, small organisms, and other particles at up to 100 times the rate of any other instrument while providing unmatched assay flexibility and providing total sample recovery. Utilizing patented acoustic technology, these features make the VeloCytTM a major advance for a wide array of biomedical research applications including rare cell detection for numerous diseases and the rapid discovery of new pharmaceuticals for the treatment of cancer and other diseases. In addition to the VeloCytTM, BennuBio is developing new products for rare cell sorting and the generation of 3D tissue models for disease research.
For more information please see www.bennubio.com, email [email protected],
call +1 (505) 246-6901, or follow us at @BennuBio on Twitter, or
https://www.linkedin.com/company/bennubio-inc/
"We believe BennuBio's innovative cell and particle analysis platform will play an important role in high-growth research markets throughout the life sciences and potential clinical applications," stated Xin Huang, Managing Partner at Co-Win Ventures. "BennuBio has developed innovative patented technologies and an exciting new flow cytometer and with this new funding is now positioned to accelerate their growth."
About Co-Win Ventures
Co-Win Ventures focuses on early-stage investments in technology and healthcare companies in both China and the United States. Founded in 2009, Co-Win has managed thirteen RMB funds and two USD funds with over 3.7 billion RMB (530 million USD) under management. Co- Win currently has more than 50 healthcare portfolio companies in pharmaceuticals, medical devices, diagnostics, and digital health sectors. Co-Win aims to identify world-leading biotech and medtech innovations with global intellectual properties and to leverage the vast clinical resources in China to speed up the R&D process and value-inflection of portfolio companies. Their portfolio includes many successful companies including Thrive, Cytek, PGDx, and GeneCast among many others. For more information, please visit http://en.cowinvc.com/index.html.
About Tramway Venture Partners
Tramway Venture Partners is an early-stage venture fund investing in biotech, Medtech, and health tech. Typically, Tramway invests in the first institutional round after incubators and angel investors. The best fit with this strategy is a company led by an outstanding management team, that has a significant intellectual property position, clear go-to-market strategies, and a large addressable market. For more information please visit https://www.tramwayventures.com/about.php.
About Cottonwood Technology Fund
Cottonwood Technology Fund is a top-decile performing early-stage venture capital fund. Cottonwood Technology Fund is active on two continents (USA & Europe) and has offices in the USA and in The Netherlands. Cottonwood Technology Fund provides disruptive capital to disruptive technology businesses. Cottonwood's investment approach and focus is on hard science, pre-seed, seed and early-stage funding (Series A). For more information please visit https://www.cottonwood.vc/.
About Sun Mountain Capital
Sun Mountain Capital is a diversified private equity firm with investment strategies in both direct investment and fund of funds programs spanning venture capital, mezzanine debt, and growth equity. Sun Mountain Capital was founded in 2006 by a team of senior investment professionals. The team has continued to grow since the Firm's founding and today encompasses a broad network for deal sourcing and best in class investment diligence and analysis. Post investment, the Firm provides value-adding investment management through the board of director positions in portfolio companies and membership on Limited Partner Advisory Committees. For more information please visit https://sunmountaincapital.com/.
Media Contact
Gary
510-305-3855
609 Broadway Blvd NE
Source :BennuBio, Inc
This article was originally published by IssueWire. Read the original article here.
A flaw in Git can let a malicious repository run an attacker's code on a computer that clones it recursively, together with its submodules. The Git project fixed it this week in Git 2.56.1, with matching fixes for the 2.50 through 2.55 series in 2.50.2, 2.51.3, 2.52.1, 2.53.1, 2.54.1 and 2.55.1. The flaw, tracked as CVE-2026-111760, is an integer truncation in how Git handles its index. An
Read moreAn attacker exploited a remote code execution flaw in SGLang, an open-source inference engine, and ran code on one of NEAR AI's inference servers last Sunday. The attacker could also have seen requests being processed on that server that day, including requests sent in confidential mode, the company said earlier this week. That mode processes requests inside a trusted execution environment (TEE
Read moreGmail users are being warned about a disturbing new hacking threat that could allow cybercriminals to secretly access their private messages and banking details.
Read moreFrench software company Vates VMS has warned of a critical security vulnerability in Xen Orchestra that it said is being actively exploited in the wild. The authentication bypass flaw, which does not yet have a CVE identifier, is tracked as VSA-2026-062. "REST cookie parsing turns authenticationToken=j:%7B%7D into {}," Vates VMS said in an alert. "REST authentication passes that object to the
Read moreA panel of scientific experts will convene on Tuesday to evaluate the United States’ measles elimination status. But genetic data already shows the virus is once again endemic.
Read moreThe AI company behind the Claude chatbot will offer its shares at between $70 and $78, which is lower than what was expected.
Read moreThe hunt for Noah's Ark has taken a dramatic turn as the first photographs emerge of wood unearthed deep beneath a mountainside in Turkey.
Read moreThree distinct threat activity clusters with shared infrastructure and malware code similarities have been observed targeting telecommunications providers, government organizations, military entities, research institutions, and critical infrastructure across Latin America, Asia, and Europe over the past year. Check Point Research is tracking the clusters under the names SilentDelivery,
Read moreThe A.I. company’s pricing would make it one of the biggest ever public listings. It comes at a volatile moment in markets, with investors questioning the sustainability of the A.I. boom.
Read moreThe FBI and other US agencies are warning that America may soon see attacks on its food supply, sending prices skyrocketing before the holidays.
Read moreMore than a decade after transforming doorbells into security cameras, Amazon has unveiled a flying robot that can patrol your home on command.
Read moreCybersecurity researchers have disclosed details of an attack that exploited two now-patched vulnerabilities in AhsayCBS to deliver a Python-based implant. The activity, observed by Huntress in early October 2026, involves the exploitation of a chain comprising CVE-2026-105133 and CVE-2026-105134 to bypass authentication and execute arbitrary commands on affected systems. Patches for the two
Read moreYOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.
